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Activation ofhuman Tlymphocytes can be initiated throughtwo majorpathways:
one ofthese is antigen specific, whereas the other is antigen independent. Antigen-
specific activation is mediated via the TCR (CD3Ti) complex, which transducer
signalsafterinteractingwithprocessed antigenin conjunction with MHC gene prod-
ucts. Similar activation can be induced experimentally by crosslinking the CD3Ti
complex with antibodies directed against individual TCR subunit proteins (1-3).
An alternative antigen-independent pathway has been described based upon the in
vitro observation that perturbation of the CD2 (T11) molecule with a combination
of antibodies defining two different epitopes (anti-T112 and antiT113) is able to in-
duce cell activation and proliferation (4). The physiological counterpart of anti-
T112+3 is still unknown; however, the cell adhesion structure LFA-3 appears to be
one natural ligand for CD2 (5) that could provide part ofthe activation stimulus
mediated by anti-T11 antibodies in vitro (6, 7).
Interaction of membrane receptors with appropriate mitogenic stimuli for the
antigen-specific and alternativepathways resultsin a virtuallyidentical series ofevents
involvingphosphatidyl inositol turnover with subsequent production of 1, 4, 5 ino-
sitol trisphosphate (IP3)' and diacylglycerol (8, 9). IP3 is directly responsible for a
rise in intracellular free calcium ([Ca2+]i) as a consequence of mobilization from
intracellular stores (10) and/or transmembrane calcium flux (11, 12), while diacyl-
glycerol is an endogenous activator ofprotein kinase C (13). Previous studies have
shown that both a rise in intracellular free calcium [Ca2+]i as well as phosphoryla-
tion events mediated throughprotein kinase C activation are necessary forIL-2 gene
induction (14).
Given the similaritiesinearly signal transduction via CD3Ti and CD2 structures
andtheir coexpression onthe surface ofmature T lymphocytes, theinterdependence
ofthe twopathways has been suggested, but remains tobe fullyinvestigated. Herein,
we describe the production and characterization ofCD2-CD3Ti+ variants derived
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from the Jurkat CD2' CD3 Ti+ human T cell line. These mutants express normal
levels of CD3Ti-a/p molecules but lack any detectable surface CD2 molecules as
judged by immunoprecipitation experiments and Scatchard analysis. Nevertheless,
functional studies clearly establish that thesecells can be activated via their CD3Ti
receptor, retaining the capacity to mediate all the aforementioned events associated
with the transduction of activation signals. Assuming that Jurkat cells are represen-
tative of their normal cycling cellular counterparts, we conclude that CD2 is not
required to activate mature T lymphocytes through their TCRs.
Materials and Methods
Cells.
￿
Variants ofthe Jurkat T cell line (cloneJ77-6.8, kindly provided by Dr. K. Smith,
Dartmouth Medical School, Hanover, NH) lacking surface expression of the CD2 molecule
were derived by mutagenesis, immunoselection, and all sorting, as previously described (15).
Briefly, 107 cells were irradiated (300 rad) in a y cell irradiator (model 1,000; Atomic Energy
of Canada Ltd., Ontario, Canada) using a 117cesium source. After 5 d in culture, cells were
incubated 1 h at room temp with a mixture of antiTll 1 (clone 3Pt2H9) and antiT112
(lold241C) ascites used at a 1 :100 finaldilution. Rabbit sera (Pel-Freeze Biologicals, Rogers,
AR) at a dilution of 1 :3 was added as a source of complement for 1 h at 37°C. The procedure
was repeated four times and viable cells were isolated by centrifugation over a Ficoll-Hypaque
density gradient (Pharmacia Fine Chemicals, Piscataway, NJ). CD3' Ti' CD2- cells were
sorted using an Epic V cell sorter (Coulter Electronics Inc., Hialeah, FL) and cloned at 1
cell/well. 19 CD3'Ti'CD2- colonies were obtained, and three ofthese clones, termed Tll - a,
T11 - b, and Tll - c, were randomly selected and extensively characterized.
Indirect Immunofuorescence Assays.
￿
Phenotypic analyses were performed usingindirect im-
munofluorescence assays with a fluorescein-conjugated goat anti-mouse IgG (Meloy Labora-
tories Inc., Springfield, VA) second antibody. 104 cells were analyzed in each sample and
results were expressed as histograms displaying number of cells vs. fluorescence intensity
on a log scale. Antibodies used in the study were anti-T3 (RW28C8, Leu-4), anti-Ti (9H5,
directed against a clonotypic determinant present on Jurkat), antiTII1 (3Pt2H9), anti-T112
(lold241C), and ant-T113 (lmono2A6). An irrelevant ascites (1HT4-4E5) was used as a con-
trol of fluorescence background. Antibodies were used at saturating dilutions in the assay
(1 :200 final dilution).
Immunoprecipitations.
￿
2 x 10' cells were surface labeled with 1251 (IMS30, Amersham
Corp., Arlington Heights, IL) for 15 min at room temperature using a standard lactoperoxi-
dase method. Labeled cellswere washed and cell lysates were prepared by resuspending the
cell pellet in 400 pl of radioimmunoprecipitation assay (RIPA) buffer containing 1% Triton
X-100, 0.15 M NaCl, 0.01 M NaH2PO4, 1 mM EDTA, 1 mM EGTA, 1 mM Naf, and pro-
teaseinhibitors, and by agitating for 40 min at 4°C. Celllysates were then extensively precleared
with formalin-fixed Staphylococcus aureus bacteria and protein A-Sepharose 4B beads (Phar-
macia Fine Chemicals) bound to a nonreactive antibody (anti-T8). Aliquots of precleared
lysates were subsequently incubated with specific antibody (either antiT3 or anti-T11 1 anti-
bodies) coated protein A-Sepharose beads for 6 h at 4°C. Immune precipitates were washed
four times with RIPA buffer and submitted to SDS-PAGE analysis aftertreatment with 5%
2-ME (reducing conditions). Gels were dried and radiolabeled precipitates were visualized
by autoradiography after 3 d of exposure.
Binding Assays. Purified anti-T111 antibody (3Pt2H9) was labeled with 10 ul of immobi-
lizedlactoperoxidase/glucose oxidase (Enzymobeads; Bio-Rad Laboratories, Richmond, CA)
in 40 mM sodium phosphate, pH 7.2, 0.4% glucose, and 1 MCi 1251 for 5 min and sepa-
rated over a 1 ml Biogel P-6 column (Bio-Rad Laboratories). 0.1-6 x 106 cpm labeled anti-
body (sp act 104 cpm/pmol) was added to 106 cells overlayed onto 0.2 ml of a 1.5:1 mixture
of dibutyl phthalate:dioctyl phthalate (Aldrich Chemical Co., Milwaukee, WI). After 30 min
at 4°C, tubes were centrifuged (8,500 g for 1 min), the tips of the tubes containingthe cell
pellets were cut, and the cell bound and free radioactivity was determined in a gamma counter.
Nonspecific binding ofthe antibody was evaluated by performingthe experimentin the pres-MOINGEON ET AL .
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ence of an excess ofcold antibody (ascites used at a 1 :50 dilution) and was subtracted from
total binding, with specific binding representing 95% of total binding.
Northern Blot Analysis.
￿
Total RNA was extracted from 10' cells using the VRC method
(Vanadyl Ribonucleoside Complex, New England Biolabs, Beverly, MA). 20-25 Rg ofRNA
per lane were run over a 1.3% agarose gel and blotted onto a Gene Screen Plus nylon(New
England Nuclear, Boston, MA) membrane. Prehybridized filters were hybridized with a PBl
(Barn HI fragment) probe (16) labeled with 32P using the random priming method to a sp
act of 108 cpm/pg DNA. Filters were washed at 65°C with 2x SSC 0.5% SDS, then 0.5x
SSC 0.5% SDS, and exposed for 18-36h with intensifying screen (DuPont Co., Wilmington,
DE). The positions of28S and 18S RNA are given as a reference. For HC21 gene expression
(H. C . Chang and E. L. Reinherz, submitted for publication), cells were stimulated either
with antiT3, antiT112 and antiT113 antibodies, or .calcium ionophore in the presence of
PMA (5 ng/ml finalconcentration), before extracting the RNA. Northern blotswere hybrid-
ized with the 640-bp HC21-h probe and washed as above.
Analysis of Phosphatidyl Inositol Turnover.
￿
Inositol metabolites were analyzed as previously
described (17). Briefly, 107 cells were incubated in 1 ml of Hepes-buffered (pH 7.4) Hank's
solution supplemented with 0.5% gelatin and 40 pCi of [3H]myo inositol (New England Nu-
clear) for 3 h at 37°C. Cells were diluted 10-fold in RPMI 1640 medium containing 10 1Y0
FCS and incubated overnight at 37°C, then washed and resuspended in 2 ml of 10% FCS,
10 mM Hepes buffer, pH 7.4, RPMI 1640 containing 10 mM LiCl (to inhibit the metabolism
of inositol phosphates to inositol). Cells were then triggered either with ascites (used at a
1 :200 final concentration) antiT3 (2Ad2A2), anti Ti, anti-T112 and anti-T113, or antiT111 an-
tibody (3Pt2H9, shown to bind to the CD2 molecule without inducing activation) (4). After
a 10-min incubation at 37 °C, cells were rapidly pelleted and lysed with 0.75 ml of chloro-
form/methanol/HCI (at a ratio of 100:200:2) before extraction ofthe inositol phosphatesand
separation over a Dowex column (Sigma Chemical Co., St. Louis, MO) (17). Inositol phos-
phates IP,, IP2, and IP3 were eluted together with 2 M ammonium formate, 0.1 M formic
acid solution. Fractions of0.4 ml were collected and counted in the presence ofaquasol (New
England Nuclear).
Determination of Cytosolic Cat* .
￿
Cells were loaded with 2 pg/ml of the acetoxymethylester
of indo-1 (Molecular Probes, Junction City, OR) in RPMI 1640 plus 2% FCS for 45 min
at 37°C, and diluted fivefold in the same medium before running on an Epics V flow cytom-
eter using an ultraviolet laser illumination (40 mW at 351-364 nm) provided by an argon
ion laser (Innova 90-5; Coherent Laser Products, Palo Alto, CA). After Cat* binding, the
indo-1 dye exhibits changes in fluorescence emission wavelengths from 480 to 410 nm (18).
The ratio of 410:480 nm indo-1 fluorescence was recorded vs. time. The short wavelength
fluorescence was detected through a 410-nm bandpass filter after being reflected by a blue
reflective dichroid, and the longer wavelength fluorescence was detected through a 480-nm
bandpass filter after passing through the same dichroic. Fluorescence ratio determination
allows measurements of Cat* increase independent of variability of intracellular dye con-
centration. Samples were analyzed at room temperature by running the indo-l-loaded cells
for 1 min to determine the baseline, then adding stimulating antibodies: antiT3 (2Ad2A2,
IgM), antiTi (IgG2) at a 1 :100 final dilution, or antiT112 and antiT113 (IgG2 and IgG3,
respectively) at a 1 :100 final dilution. In some experiments, the calcium ionophore A23187
(Sigma Chemical Co.) was added at a 1 pg/ml final concentration as a positive control. Samples
were analyzed for 6 min and results are expressed as Cat* increase in ordinate (fluorescence
ratio is given in arbitrary units) vs. time in min (abscissa). One arbitrary unit represents
-200 nM of Cat* rise (as evaluated in quantitative parallel experiments using the quin-2
fluorescent dye).
IL-2 Production Assay.
￿
Evaluation ofIL-2 production was assayed as previously described
by Marrack et al. (19). 5 x 10" cells were plated in 96-well round-bottomed plates (final
volume, 0.2 ml) and incubated at 37°C with anti-T3 (2Ad2A2), anti-Ti at a 1 :200 final dilu-
tion or antiT112 and anti T113 antibodies at a 1 :100 final dilution in the presence of 5 ng/ml
of PMA (Sigma Chemical Co.). Supernatants were harvested after24 h and titrated in dupli-
cate in serial twofold dilutions (ranging from 1 :4 to 1 :4,096) for their ability to support the
growth ofthe IL-2-dependent cell line CTLL20. The highest dilution ofculture supernatant2080
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able to maintain 5 x 103 CTLL20 viable cells (as evaluated in a trypan blue exclusion assay)
was said to contain 1 U of IL-2. Results were expressed as arbitrary U/ml IL-2 secreted.
We estimate one arbitrary unit to be equivalent to 0.25 U of rIL-2 from Biogen (Cambridge,
MA).
Cell Transfection.
￿
For reconstitution of CD2 expression on T11 - mutants, the full-length
Tll cDNA (clone PB2) (16) was inserted into the Bam HI site of the pPink-2 vector (kindly
provided by Dr. P Ohashi, Toronto, Canada), in which expression of the cDNA insert is
under the control of the spleen focus-forming virus long terminal repeat (LTR), while the
presence ofthe neomycin gene provides a selection marker for the antibioticG418. Such gener-
ated plasmids were grown in Escherichia coli strain HB101 and amplified in the presence of
chloramphenicol. Culture was converted to protoplasts and fused to the Tll - c cells in the
presence of 40% polyethylene glycol 1500 as previously described (15). After 48 h, cells were
plated at 30,000 cells/well in 96-well flat-bottomed microtiter plates in the presence of2 mg/ml
geneticin G418 (Gibco Laboratories, Grand Island, NY). Resistant clones were selected for
CD2 expression using an indirect immunofluorescence assay, and cells were maintained in
culture in the presence of 0.5 mg/ml G418.
Results
Selection of CD3Ti+ CD2- Variants of theJ77 Cell Line.
￿
Variants of the jurkat cell
line, cloneJ77-6.8 lacking the CD2 molecule, were obtained by mutagenesis, im-
munoselection, and cell sorting (see Materials and Methods). CD2 - colonies were
screened by indirect immunofluorescence: 19 clones displaying the CD3Ti+ CD2 -
phenotype were obtained and three of these clones, termed Tll - a, Tll - b, and
Tll - c, were randomly selected and used for further characterization. The pheno-
type of one of these CD2 - variants (T11 - b) is shown in Fig. 1. Antibodies directed
to different epitopes of the CD2 molecule failed to react with the T11 - variants,
while all three of these epitopes were found to be expressed on the J77 parental cell
line. Furthermore, CD3 and Ti expression as judged by peak mean channel fluores-
cence intensity was clearly comparable onJ77 and Tll - clones, suggesting the pres-
ence of a similar number of TCR complexes with no discernable requirement for
CD2 protein in CD3Ti surface expression. An identical set of reactivities was ob-
served for clones Tll - a and T11 - c (not shown).
anti-CD3
antiTi
antiJ111
anti -T112
antiT113
J77
￿
Titb
2 0
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Log f0 Relative Fluorescence
FIGURE 1.
￿
Phenotypic analysis ofJ77 and CD2- cell
lines. Reactivity ofdifferent mAbs with J77 and CD2-
variant cells was assayed by indirect immunofluorescence
using cytofluorimetric analysis. 104 cells were run per
sample and the diagrams represent the number of cells
(ordinate)vs. intensity offluorescenceexpressed in a log-
arithmic scale (abscissa). Reactivity of the different anti-
bodies (thick line) is compared withbackground offluores-
cence obtained with an irrelevant antibody (thin line).MOINGEON ET AL .
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CD2 Molecules Are Undetectable on the Surface of CD2- Variants.
￿
As an alternative
approach forthe identification ofCD2 molecules, immunoprecipitation experiments
were performed on theJ77 parental line, and on T11 -a and T11 -c clones . To this
end, lysates from surface-labeled cellswere immunoprecipitated either with purified
antiT11 i or antiT3 antibody linked to protein A-Sepharose beads and im-
munoprecipitates washed and analyzed by SDS-PAGE . As shown in Fig . 2 a, anti-
T111 immunoprecipitates a 50-kD protein fromJ77 (lane C) . In contrast, even over-
exposure of the autoradiogram failed to reveal any corresponding band from T11-
cells (lanesA and B) . Anti-T3 antibody precipitates theCD3 subunits on the three
cell lines (lanesD-F) that appear as two bands of-27 and N21-kD from theJurkat
cell line . Parallel immunoprecipitation conducted with the antiTi antibody on T11 -
variants and177 cells established that aTi molecule with similarbiochemical char-
acteristics was also present on these cells (our unpublished data) .
Asamore quantitative meansofassessingnumbersofCD2 moleculeson theJurkat
variants, a radioisotope binding assaywasdeveloped using 1251-labeled anti-T11 1 an-
tibody. As shown in Fig . 2 b, a high and saturable specific binding was observed
onJ77 cells . Scatchard analysis of the data indicated the presence of "14,000 sites
per cell (not shown). By contrast, no specific binding was detected on T11-c. Similar
data was observed with T11-a and T11 -b clones . Given the sensitivity of this
binding method, we estimate that the T11 - mutants must express <100 Tll mole-
cules on their cell surface. Using an identical methodology with 1251-labeled anti-
T3 and anti-Ti antibodies, we determined that J77 and T11 -c each expressed
FIGURE 2 .
￿
Absence ofdetectable CD2 protein on variant cell lines . (a)J77 andTll-aandT11 - c
cells were iodinated before lysis and immunoprecipitation with anti-T11 1 (lanes A-C) or antiT3
antibodies (lanes D-F) . Immunoprecipitates were analyzed in 12.5% polyacrylamide gel in the
presence of5% 2-ME . Lanes A and D, Tll - a cells ; lanes B and E, Tll - c cells; lanes C and
F, J77 cells. (b) Binding assays were conducted with 12'1 anti-T11 I as described in Materials and
Methods . Specific bindingwas obtained by subtracting nonspecific binding from total binding .
Results are expressed as mean of a triplicate determination (SD <5%) .2082
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"10,000 copies ofTCRs. Thus, thelevel ofCD3Ti expression is notdependentupon
CD2 expression .
Analysis o,fCD2 Gene Expression in CD2- Variants.
￿
To identify whether the loss of
CD2 surface expression was due to a pretranslational effect, blot analysis was per-
formed withRNA isolated from the T11- a, T11 - b, and T11 -c cells . 25 ttg of total
RNA was run on a 1.3% agarose gel, transferred to Gene Screen Plus membrane,
and probed with the 32p-labeled T11/cDNA, PBl . As shown in Fig. 3, hybridiza-
tion with the PB1 probe revealed two transcripts of 1 .7 and 1.3 kb specifically in
the T cell line J77 (lane A) . In contrast, the CD2 transcripts were not detectable
in the B cell line Laz 509 (lane E) . Although some level of CD2 gene transcription
was detected in all three T11 - mutants (lanes B, C, and D), this was substantially
reduced in comparison with the parental cell line (up to 20-fold reduction) . Note
that the 1 .7-kb transcript predominates in the T11-a and T11 -b clones, whereas the
1.3-kb transcript predominates in the T11-c clone. Given the fact that either form of
CD2message can give rise to functionalCD2 protein, we cannot exclude an extremely
low translational level in these mutant cells . Presumably, the irradiation-induced
mutagenesis has resulted in a defect in the regulatory region of the CD2 gene or
another cis- or trans-acting regulatory element affecting CD2transcription . The pos-
sibility that irradiation has introduced a point mutation in the CD2 sequence that
affects message stability or translatability also cannot be ruled out .
Phosphatidyl Inositol Turnover .
￿
To characterize the status of early membrane sig-
naling events in these T11 - mutants, induction of PI turnover was evaluated after
stimulation viaCD2 or C133-Ti . To this end, J77 and T11 -a and T11 - c cells were
labeled with [3H]inositol and stimulated with anti-T3, anti-Ti, or a combination of
antiT112 and antiT113 antibodies . As a negative control, clones were stimulated
with an antibody directed against a nonmitogenic epitope, antiTll.t (4) . Results
from a representative experiment are shown in Table I . As indicated, anti-T112 and
anti-T113 dramatically increase PI turnover inJ77; a 6.3-fold increase of inositol
FIGURE 3 .
￿
Northern blot analysis ofCD2gene expres-
sion . RNA was extractedfrom the cytoplasmic fraction
ofJ77, Tll - variants, and the EBVtransformed B cell
line (Laz 509) and25 ugofRNArunper lane. The blot
was hybridized with the 32P-labeled PBl cDNA probe,
washed, andexposed for 22 h . Lane A, J77 ; lanesB-D,
Tll- a, Tll - b, and T11 - c, respectively; lane E, Laz
509 .MOINGEON ET AL .
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TABLE I
Determination of Phosphatidyl Inositol Turnover in
J77 and T1 I - Mutants upon CD2 and CD3-Ti Activation
Results are expressed in cpm of [3H]myo inositol incorporated in monophosphate (IPI) + his-
phosphate (IP2) + trisphosphate (IP3) . Numbers in parentheses represent percentage change
in comparison to incubation with the nonactivating (control) anti-Tlli antibody .
phosphateswas found in comparison with stimulation with thecontrol anti-T11 1 an-
tibody . In contrast, these antibodies were ineffective in stimulating T11-a and T11 -c
cells, thereby demonstrating the functional lack ofCD2 structureson these mutants .
However, when antiT3 was used to stimulate theT cell populations, a 4.1-, 3.5-,
and 4.1-fold increase in PI turnover was found for J77, T11 - a, and T11 - c cells,
respectively. AntiTi antibody, like anti-T3, was able to induce phosphatidyl inositol
breakdown in all three cell lines, although the level of activation was found to be
less than that with anti-T3 (a 1.7, 1.6, and 1.2 increase wasfound, respectively) . Thus,
PI turnover mediated via the CD3Ti pathway occurs in the absence of detectable
CD2 surface structures .
Cytosolic Ca" Measurement .
￿
To examine alteration in [Ca2+ ]i after CD3Ti or
CD2 stimulation, cells were loaded with the fluorescent dye indo-1 and triggered
with specific antibodies (Fig . 4) . As previously reported (15, 20), incubation ofJ77
FIGURE 4 .
￿
Variation ofintracellular calcium after
CD3Ti andCD2 triggering . Indo-l-loadedJ77 and
Tll - a, Tll- b, andTll -c cell lines were incubated
either with antiTI12f 3, antiT3 and antiTi ascites
(blackarrow), or calciumionophore (open arrows), and
sampleswere monitored continuously for6 minon
an Epics V cell sorter. Results are expressed as
410/480nm fluorescence ratio in arbitrary units (or-
dinate) vs. time in minutes (abscissa) .
Cells Anti-T11I Anti-T111 +
mAbs
anti-T113 Anti-T3 Anti-Ti
J77 7,434 46,842 (630) 30,271 (410) 12,325 (170)
Tll - a 4,214 4,199 (99) 14,617 (350) 6,953 (160)
Tll - c 4,815 2,566 (53) 19,786 (410) 6,126 (120)2084
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cells with antiT112 and antiT113 antibodies results in a dramatic increase in cyto-
solic calcium as detected by a shift in the wavelength of fluorescence emission of
indo-1 from blue to violet . By contrast, identical stimulation of T11 - cells does not
induce any change in [Ca2+ ]i . Furthermore, although not shown, this was not a con-
sequence ofarequirement forahigher antibody concentration with which to trigger,
since purified antiT112 and antiT113 antibodies at any concentration tested also
failed to stimulate a rise in [Ca2 + ] ; (not shown) . This functional data adds further
support for the above results in which immunoprecipitation analysis and binding
assays showed absence of surface CD2. Note that treatment of theseCD2- cells with
the calcium ionophore A23187 leads to an immediate rise in [Ca2 + ]i, demonstrating
that the CD2 - cells take up indo-1 without difficulty and are loaded equivalently
to J77 . Furthermore, incubation of cells with anti-T3 antibody induces a calcium
rise in J77 as well as in the three T11 - mutants with similar kinetics (after -30 s)
and maintenance of an equivalent level offluorescence during the subsequent 6 min
ofthestudy . Interestingly, stimulation with antiTi antibody induces avirtually identical
increase in [Ca21 ] ; in J77 and T11 - a, T11 - b, and T11 - c cell lines but the rise is
more transient than with antiT3 and reverts to background level within 2 min .
HC21 Gene Induction .
￿
The above studies analyzed the early membrane signaling
events known to be associated with T lymphocyte activation . To next assess other
intracellularactivation events, we examined the expression of early activation genes
(HC21) and endogenous IL-2 production in CD2 + and CD2- Jurkat cells . Induc-
tion ofthe HC21 gene occurs inT lymphocytes stimulated either through theCD2
molecule or theCD3Ticomplex but not the IL-2-R (Chang,H . C. andE. L. Rein-
herz, submitted for publication) . This gene encodesa0.8-kbRNAofunknownfunction
that is detectable in northern analysis within 10 min of stimulation . As shown in
Fig. 5, calcium ionophore plusPMA treatment results in a high level of transcrip-
tion of the HC21 gene in both CD2 - (lane H) and CD2+ (lane D) cell lines . As
expected, the 0.8-kb HC21 mRNA is also found inJ77 after stimulation with anti-
T112 and antiT113 plus PMA antibodies (lane C), while this transcript is not de-
tected in T11 -b cells treated under similar conditions (lane G) . Importantly, com-
parable levels of HC21 expression are found in J77 and T11 -b cells after anti-T3
plusPMA stimulation (lanesB and F, respectively), strongly indicating that detect-
able surface CD2 expression is not required for HC21 induction .
IL-2 Production.
￿
IL-2 production and secretion by CD2 + and CD2 - Jurkat
FIGURE 5 .
￿
HC21 gene induction inJ77 and T11 -b
cells . Northern blot analysis was performed using 25
t<g ofRNA from J77 and T11 - b cells using the 32P-
labeled HC21-h probe. Lanes A-D, J77 cells ; lanes
E-H, T11 -b cells . Stimuli used in combination with
PMA were : culture medium (lanes A and E) ; anti-
T3 (lanes Band F); anti-T11 213 (lanes Cand G) ; or
calcium ionophore (lanes D and H) .MOINGEON ET AL.
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populations was evaluated after stimulation as described in Materials and Methods.
As shownin a representative experiment (Table II), supernatants of cells incubated
with PMA alone contain only low levels of IL-2 (48 U/ml). Addition of antiT112
and anti-T113 antibodies inducesJ77 cells to produce high levels of IL-2 (up to 2,048
U/ml), but is without any effect on CD2- mutants. Anti-T3 or antiTi antibody
stimulation leads to significant IL-2 production in alltested cell lines (128-256 U/ml).
It should be noted that since serial twofold dilutions were used in the assay, we as-
sume that results obtained by CD3Ti stimulation and expressed in Table II do not
represent any quantitative difference betweenJ77 and T11- clones. Thus, surface
CD2 expression is not required forIL-2 production afterCD3Ti stimulation ofJurkat-
derived cells.
Reconstitution ofSurface CD2 Expression on the T11-c Clone.
￿
The above studies in-
dicated that the T11 - mutants could not be triggered to undergo early biochemical
activation events upon stimulation with anti-T112 and anti-T113 antibodies. To prove
whetherthis defect was adirect consequence ofthe absence of the CD2 gene product,
we performed reconstitution analysis. To this end, a full-length cDNA clone (PB2;
reference 16) was transfected into Tll- c cells using a previously described protoplast
fusion method (15). After G418 selection and immunofluorescence screening, CD2+
clones were identified. Fig. 6 (left panel) represents the immunofluorescence analysis
of one reconstituted T11- c clone, termed T11- cR, which clearly expresses both CD3
and CD2 molecules. Note that the level of CD2 expression in T11- cR cells is less
than that of the parental Jurkat cell line, but clearly detectable unlike the Tll - mu-
tants (Fig. 1). Stimulation of T11- cR by anti-T11 2 and anti-T113 antibodies induced
a readily detectable rise in [Ca2 +]; in a substantial number of cells (Fig. 6, right
panel). As expected, reconstitution of surface CD2 expression did not alter the ca-
pacity to stimulate cells via CD3Ti molecules since both T11- c and T11 - cR cell
lines were found equally triggerable through their TCRs (data not shown).
Discussion
CD2- mutants have been derived and characterized from the CD2+CD3Ti+
Jurkat humanTcell line. Surface expression ofthe CD2 molecule was undetectable
using a series of mAbs directed at three different epitopes of the CD2 structure
(T111, T112, T113) and any of three separate assays: indirect immunofluorescence,
TABLE II
IL-2 Production in J77 and T11 - Mutants upon CD3-Ti and CD2 Stimulation
Cells were incubated for 24 h with the different stimuli and supernatants were harvested and
tested in duplicate in serial dilutions for their ability to affect the growth of 5 x 103 CTLL20
cells. Results are expressed in arbitrary IL-2 units as defined in Materials and Methods.
Cells PMA (5 ng/ml)
Anti-T112
anti-T113 +
Stimuli
+
PMA Anti-T3 + PMA Anti-Ti + PMA
J77 <4 2,048 128 256
T11 - a <4 <4 128 128
Tl l - b <4 <4 256 256
T11 - c 8 8 128 1282086
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FIGURE 6 . Characterization of a
reconstituted TIl-cR clone . (Left
panel) Reactivity ofanti-CD3 and anti-
CD2 antibodies (thick lines) as assayed
by indirect immunofluorescence . 104
cells were analyzedper sample and the
diagrams represent thenumberof cells
(ordinate) vs . intensity of fluorescence
expressed in a logarithmic scale (ab-
scissa). Background of fluorescence (thin
line) wasobtainedwith an irrelevant an-
tibody. (Right panel) Indo-l-loaded
T11 -cR cells were incubated with
anti-T112 and anti-T113 antibodies
(black arrow) and the sample wasmoni-
tored continuously on an Epics V cell
sorter. Results are expressed as 410:480
nm fluorescence ratio (ordinate) vs . time
(abscissa) .
immunoprecipitation-SDS-PAGE, and radiolabeled antibody binding. Furthermore,
the T11 - a, T11- b, and T11-c clones were incapable of being activated by a combi-
nation of antiT112 and antiT113 antibodies, which are extremely potent in
stimulating theparentalJurkat clone and restingperipheralTlymphocytes (4) . Thus,
measurement of alterations of[Ca2+]i, HC21 gene induction and IL-2 production,
all sensitive assays ofT lymphocyte activation, gave no evidence for stimulation of
T11 - mutants via the CD2 structure .
It should be noted that complete absence of CD2 structures cannot be formally
excluded in the three T11 - variants characterized herein given that a low level of
CD2gene transcriptionwas detected in each mutant population . However, according
to the sensitivity of the radiolabeled binding assay, these T11 - clones express, at
most, <100 molecules/cell. This corresponds to at least a 140-fold reduction in the
number of surface CD2 in comparison with the parental Jurkat line.
The basis for the defect in CD2 expression in T11 - variants is presently unknown .
Noteworthy, at the level ofRNA expression is the clear predominance of either the
1.7- or 1.3-kb message in mutant cell lines . These results raise the possibility that
themutation occurs either within a regulatory region of theCD2 gene or as- and/or
trans-activating elements important forCD2 expression . Moreover, since transfec-
tion of such T11- mutants with human CD2 cDNA driven by an exogenous LTR
results in a high level of transcription (data not shown) with surface expression of
CD2 less than the parental Jurkat cell line (compare Fig . 6, left panel with Fig . 1),
it is possible that additional defects at the post-transcriptional level (e.g ., defect in
a transport system of the molecule to the membrane) could lead to lack ofnormal
surfaceCD2 protein expression . However, such C132-reconstituted cellscan clearly
be triggered via the CD2 molecule to augment [Ca2+ ]i as expected .
One unequivocal finding of the present study is the observation that CD3 and
Ti molecules are found on the surface ofCD2- mutants and that CD2 expression
apparently has no effect on CD3Ti expression since the number of molecules of
CD3Ti on Jurkat vs . CD2- variants were quantitatively similar as judged by
binding assay . Perhaps more importantly, these same experimentsdemonstrate that
CD2- mutants can be triggered through theirCD3Ti components to mediate phos-MOINGEON ET AL.
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phoinositol turnover, a rise in [Ca2+ ]i, nuclear activation (including HC21 activa-
tion), andIL-2 gene transcription, translation, and secretion. Thus, in theseJurkat
variants, the CD3Ti-a/S receptor does not require CD2 for functional activation.
We observed in the present studythat stimulation of the CD3Ti structure with antiTi
antibody wasless effective than with anti-CD3 antibody at inducing early biochem-
ical events, including phosphatidyl inositol turnover and [Ca21 ]; rise. In contrast,
both antiTi and anti-CD3 antibodies induced similarlevels ofIL-2 production. This
result is perhapsnot surprising since it is generally assumed that the CD3 subunits
are involved in signal transduction or, at the least, linked more proximal to trans-
duction elements than the antigen/MHC binding heterodimer. That IL-2 produc-
tion is equivalent after stimulation of the CD3Ti complex viaclonotypic vs. mono-
morphic structures is perhaps also not unexpected ifonly acritical threshold alteration
in phosphoinositide turnover or [Ca2+ ]; is required for IL-2 gene induction.
Nevertheless, we cannot exclude the possibility that the avidity, isotype subclass,
or other intrinsic properties of the anti-CD3 and antiTi antibodies used in these
studies (e.g., the anti-CD3 is IgM while the anti-Ti is IgG2) are themselves respon-
sible for the differences in the early biochemical activation events.
Therelative CD2 independence oftheTCRcomplexdemonstrated herein by genetic
manipulation contrasts with the conclusion of certain other functional studies (21,
22). The latter have suggested that perturbation of the CD2 molecule with mAbs
affects subsequent stimulation through CD3Ti. Whether this is a direct effect of
CD2 in regulating activation through CD3Ti is controversial since other reports
show that modulation of CD2 moleculeshas no effect on early metabolic activation
events observed after CD3Ti triggering, including inositol breakdown and altera-
tions in [Ca2+ ]; (23). Given that modulation experiments require preincubation of
T cellsfor prolongedperiods oftime with mAbs, indirect immunoregulatory effects
cannot be excluded. The presentgenetic approach describedherein, therefore, firmly
argues for the C132-independent nature of certain TCR triggering events in Jurkat
and presumably other activated T cell populations.
A CD3+ IL-2-dependent clone lacking expression ofCD2 on the membrane has
recently been derived from peripheral blood of a healthy subject (24). This clone
was found to express components ofthe"second type" TCRy/S complex whileCD2
was undetected by indirect immunofluorescence techniques. These CD2- cells were
still able to be induced to proliferate and display cytotoxic activity after triggering
with antibodies directed against either CD3 or Ti y protein. Although no quantita-
tive binding analysis was performed to rule out detectable CD2 surface protein ex-
pression by amore sensitivetechnique, these results establishthat the physical pres-
ence of normal numbers ofCD2 molecules on the membrane ofthis cell type is also
not an absolute requirement forsubsequent expression and function ofitsTCR(24).
The above results are in marked contrast to the unequivocal evidence indicating
that CD3Ti expression is necessary foractivation ofmature Tlymphocytes through
their CD2 structure (4, 15, 25, 26). In this regard, we recently described
CD3-Ti-CD2+ mutants of theJurkat line that failed to express a 1.3-kb Ti R gene
transcript (15). These mutants were unable to be stimulated by either CD3Ti or
CD2 pathway to increase phosphoinositide turnover, mobilize calcium, or induce
theIL-2 gene. However, after reconstitution via transfection with a Ti R cDNA driven
by an exogenous LTR, CD3Ti expression was restored as well as the activation ca-
pacity through the CD2 and CD3Ti structures (15).2088
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Collectively, the above results suggest that while
Lion of T cells via
boned that these
oneCD3-Ti-'y/8
3-Ti is necessary for activa-
reciprocal is not true. Nevertheless, it has to be cau-
ns have been made on CM-Ti-a/ß jurkat clones and
clone, both ofwhich represent cycling cell popula-
tions. It remains to be demonstrated whether T cell activation can proceed from
the Go state ofcells whose CD2 structure is absent or made nonfunctional. In thi
regard, it is alikely possibility that transduction ofsignaling viaCD2 affects st
lation through the CD3-Ti complex. Compelling functional data has already been
provided to suggest that both pathways cooperate in a synergistic fashion to induce
T cell proliferation. Thus, a combination of submitogenic anti-CD3 and antiTll
antibodies together lead to Tcell proliferation(27). The ability ofCD2 to augment
ceoflowconcentrations ofantigenic stimuli that might
beencounteredduring natural immuneperturbationscouldbe ofsubstantialphysi-
ologic significance. Furthermore, the CD2 molecule appears to have an important
role in T lymphocyte adhesion by facilitating the bindingofregulatory andeffector
T cells to their cognate partners through direct interaction with the ubiquitous sur-
face structure LFA-3 (5). Since binding of CD2 to LFA-3 leads to at least one of
thesignalsrequired forT cell stimulationviaC132, aphysiologic role forthis pathway
Bested inboth themature peripheral T cellcompartment (6, 7) and the imma-
ture thymus compartment (28, 29). In this context, the role ofC132 in regulating
activation ofT lineage cellsat different stages ofontogeny, particularly those under-
going cell cycle entrance, remains to be fully elucidated.
Summary
0investigatetherequirement WCD2 expression in activation ofT lymphocy,
the CD3-Ti antigen/MHC receptor complex, we produced and characterized
a series of CD2- Jurkat variants. These mutants lack detectable surface CD2 as
determined by indirect immunofluorescence, immunoprecipitation analysis, and
specific radiolabeled antibody binding assay, but nevertheless, expressed normal
numbers ofCD3-Ti receptors. Asexpected, thecombination ofanti-CD2 antibodies,
termed anti-T112 and anti-T113, which are mitogenic for resting T lymphocytes,
failed to stimulate activation ofthese variants. In contrast, triggering oftheir CD3-
Ti components resulted in the normal set ofT lymphocyte-associated activation
including phosphoinositide turnover, elevation in intracellularfree calcium,
early gene-induction events, and IL-2 production. Assuming that the jurkat cell
line is representative of normal cycling human T lymphocytes, we conclude that
thepresenceofthe CD2 molecule ontheplasma membrane isnotin itself arequire-
ment for an operational CM-Ti-a/ß receptor.
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